5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.95▲ | 8.83▲ | 8.78▲ | 8.35▲ | 6.73▲ |
MA10 | 8.92▲ | 8.68▲ | 8.53▲ | 7.66▲ | 5.22▲ |
MA20 | 8.85▲ | 8.47▲ | 8.44▲ | 6.57▲ | 3.80▲ |
MA50 | 8.65▲ | 8.34▲ | 8.32▲ | 4.87▲ | 2.62▲ |
MA100 | 8.44▲ | 8.21▲ | 7.04▲ | 3.48▲ | 3.12▲ |
MA200 | 8.38▲ | 6.92▲ | 5.58▲ | 2.63▲ | 5.88▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.059▲ | 0.056▲ | 0.202▲ | 0.565▲ |
RSI | 65.631▲ | 68.746▲ | 67.631▲ | 74.626▲ | 83.388▲ |
STOCH | 82.323▲ | 89.380▲ | 91.161▲ | 75.028 | 84.893▲ |
WILL %R | -29.787 | -6.635▲ | -6.635▲ | -8.561▲ | -4.669▲ |
CCI | 129.849▲ | 137.816▲ | 157.764▲ | 89.053 | 202.975▲ |
Tuesday, September 16, 2025 04:12 AM
Thomas Schall Thomas Schall, Chariman of the Board of Directors of Immuneering NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company ...
|
Thursday, September 11, 2025 01:15 PM
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could ...
|
Wednesday, September 10, 2025 04:18 AM
Company plans to host an investor call at 8 a.m. ET on September 25 - - Immuneering plans to then share the updated data at the PanCAN Scientific Summit on September 28 - - Additionally, the Company ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/09/25 | 8.16 | 9.05 | 8.16 | 9.01 | 529,788 |
17/09/25 | 8.20 | 8.50 | 7.98 | 8.07 | 510,157 |
16/09/25 | 8.11 | 8.7099 | 7.94 | 8.31 | 596,284 |
15/09/25 | 8.62 | 8.8491 | 7.82 | 7.86 | 704,273 |
12/09/25 | 8.07 | 8.5899 | 7.97 | 8.49 | 858,820 |
11/09/25 | 7.67 | 8.45 | 7.65 | 8.21 | 930,890 |
10/09/25 | 7.99 | 9.37 | 7.50 | 8.14 | 3,329,691 |
09/09/25 | 6.00 | 7.16 | 5.97 | 7.05 | 1,667,547 |
08/09/25 | 5.53 | 6.05 | 5.465 | 5.95 | 837,438 |
05/09/25 | 5.48 | 5.6179 | 5.17 | 5.51 | 594,017 |
|
|
||||
|
|
||||
|
|